[1]
H. Moroz, “The impact of iron metabolism disorders, transfusion load, and the use of erythropoiesis stimulants on quality of life, therapy tolerance and long-term survival of patients with chronic myeloid leukaemia after allogeneic stem cell transplantation cells”, ScienceRise: Medical Science, no. 2(63), pp. 31–38, Oct. 2025.